Andrea Cercek

32.6k total citations · 4 hit papers
212 papers, 11.2k citations indexed

About

Andrea Cercek is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Andrea Cercek has authored 212 papers receiving a total of 11.2k indexed citations (citations by other indexed papers that have themselves been cited), including 152 papers in Oncology, 95 papers in Surgery and 69 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Andrea Cercek's work include Colorectal Cancer Treatments and Studies (88 papers), Colorectal and Anal Carcinomas (44 papers) and Colorectal Cancer Surgical Treatments (43 papers). Andrea Cercek is often cited by papers focused on Colorectal Cancer Treatments and Studies (88 papers), Colorectal and Anal Carcinomas (44 papers) and Colorectal Cancer Surgical Treatments (43 papers). Andrea Cercek collaborates with scholars based in United States, Spain and France. Andrea Cercek's co-authors include Robert A. Smith, Rebecca L. Siegel, Ahmedin Jemal, Joseph C. Anderson, Stacey A. Fedewa, Kimberly D. Miller, Ann Goding Sauer, Lynn F. Butterly, Nikita Sandeep Wagle and Jinru Shia and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Andrea Cercek

193 papers receiving 11.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Colorectal cancer statistics, 2020

2020 3.6k citations Rebecca L. Siegel, Kimberly D. Miller et al. CA A Cancer Journal for Clinicians profile →
Colorectal cancer statistics, 2023

2023 1.7k citations Rebecca L. Siegel, Andrea Cercek et al. CA A Cancer Journal for Clinicians profile →
Immunotherapy in colorectal cancer: rationale, challenges and potential

2019 1.3k citations Zsofia K. Stadler, Andrea Cercek et al. profile →
Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention

2018 369 citations Michael F. Berger, Marinela Capanu et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Andrea Cercek

Since Specialization

Citations

This map shows the geographic impact of Andrea Cercek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Cercek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Cercek more than expected).

Fields of papers citing papers by Andrea Cercek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Cercek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Cercek. The network helps show where Andrea Cercek may publish in the future.

Co-authorship network of co-authors of Andrea Cercek

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Cercek. A scholar is included among the top collaborators of Andrea Cercek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Cercek. Andrea Cercek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Minimum Requirements to Safely Establish and Sustain New Hepatic Arterial Infusion Pump Programs: An International Expert Perspective 2025 ·Annals of Surgical Oncology ·Ryan P. Merkow, Michael J. Cavnar, Ana Gleisner, Skye C. Mayo, Sepideh Gholami, Paul J. Karanicolas, Bas Groot Koerkamp, Marjolein Y.V. Homs, Louise C. Connell, Andrea Cercek, Paul R. Helft, Blasé N. Polite, Reema Patel, Hope E. Uronis, Michael I. D’Angelica, Michael E. Lidsky	0
2	Acquired High Tumor Mutational Burden and Activity of Immunotherapy after Targeted Therapy in Microsatellite Stable Colorectal Cancer 2025 ·Clinical Cancer Research ·(unknown), Oliver Artz, (unknown), (unknown), Peter Ntiamoah, Caroline Weipert, Henry Walch, (unknown), Fergus Keane, Sree B. Chalasani, Neil H. Segal, Michael B. Foote, Andrea Cercek, Andrew Pagano, Steven B. Maron, Luis A. Díaz, Christine A. Iacobuzio–Donahue, Jinru Shia, Benoı̂t Rousseau, Rona Yaeger	1
3	Colonic Adenosquamous Carcinoma: A Single-Center Review of Patient Clinicopathologic Characteristics, Genetics, and Clinical Outcomes 2024 ·Cancers ·(unknown), Hannah M. Thompson, Floris S. Verheij, Jinru Shia, Francisco Sánchez-Vega, Georgios Karagkounis, Maria Widmar, Iris H. Wei, J. Joshua Smith, Garrett M. Nash, Martin R. Weiser, Philip B. Paty, Andrea Cercek, Leonard B. Saltz, Julio García‐Aguilar, Emmanouil P. Pappou	0
4	Clinical Calculator for Predicting Freedom From Recurrence After Resection of Stage I-III Colon Cancer in Patients With Microsatellite Instability 2024 ·JCO Clinical Cancer Informatics ·(unknown), (unknown), (unknown), Maria Widmar, Iris H. Wei, Emmanouil P. Pappou, J. Joshua Smith, Garrett M. Nash, Philip B. Paty, Julio García‐Aguilar, Andrea Cercek, Zsofia K. Stadler, Neil H. Segal, Jinru Shia, Mithat Gönen, Martin R. Weiser	1
5	Final results of a phase 2 study of tucatinib and trastuzumab for HER2-positive mCRC (MOUNTAINEER). 2024 ·Journal of Clinical Oncology ·John H. Strickler, Andrea Cercek, Salvatore Siena, Thierry André, (unknown), Eric Van Cutsem, Christina Wu, Andrew Scott Paulson, Joleen M. Hubbard, Andrew L. Coveler, Christos Fountzilas, Adel Kardosh, Pashtoon Murtaza Kasi, Heinz‐Josef Lenz, Kristen K. Ciombor, Élena Elez, David L. Bajor, (unknown), Wentao Feng, Tanios Bekaii‐Saab	2
6	Extrahepatic Cholangiocarcinoma: Genomic Variables Associated With Anatomic Location and Outcome 2024 ·JCO Precision Oncology ·William Preston, Esther Drill, Thomas Boerner, Rebecca Gelfer, James J. Harding, Eileen M. O’Reilly, Andrea Cercek, Ghassan K. Abou‐Alfa, Wungki Park, Vinod P. Balachandran, Jeffrey A. Drebin, Kevin C. Soares, Alice C. Wei, T. Peter Kingham, Michael I. D’Angelica, William R. Jarnagin	3
7	A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS‐102 in irinotecan‐refractory metastatic colorectal cancer patients 2024 ·International Journal of Cancer ·Valerie Lee, Rose Parkinson, Marianna Zahurak, Leslie Cope, Andrea Cercek, Henk M.W. Verheul, Elske C. Gootjes, Heinz Josef Lenz, Syma Iqbal, Peter A. Jones, Stephen B. Baylin, (unknown), Nita Ahuja, (unknown), Nilofer S. Azad	7
8	Molecular and Clinicopathologic Impact of GNAS Variants Across Solid Tumors 2024 ·Journal of Clinical Oncology ·Paul Johannet, (unknown), (unknown), (unknown), Henry Walch, Benoı̂t Rousseau, Guillem Argilés, Oliver Artz, Mitesh Patel, Andrea Arfè, Andrea Cercek, Rona Yaeger, (unknown), Nikolaus Schultz, Luis A. Díaz, Michael B. Foote	5
9	Incomplete cytoreductive surgery for appendiceal and colorectal peritoneal carcinomatosis: Characteristics and outcomes of an overlooked group 2023 ·Journal of Surgical Oncology ·Paolo Goffredo, (unknown), (unknown), David A. Kleiman, Andrea Cercek, J. Joshua Smith, Philip B. Paty, Martin R. Weiser, Julio García‐Aguilar, Garrett M. Nash	3
10	Case-Based Clinical Guidance on Dosing and Management of the Hepatic Artery Infusion Chemotherapy Pump 2023 ·JCO Oncology Practice ·Devika Rao, (unknown), Nancy E. Kemeny, Andrea Cercek	5
11	The Impact of Germline Alterations in Appendiceal Adenocarcinoma 2023 ·Clinical Cancer Research ·Michael B. Foote, Henry Walch, Yelena Kemel, Efsevia Vakiani, Paul Johannet, Margaret Sheehan, Walid K. Chatila, Sebastian Chung, Garrett M. Nash, Anna Maio, Jinru Shia, Diana Mandelker, Michael F. Berger, Nikolaus Schultz, Luis A. Díaz, Andrea Cercek, Zsofia K. Stadler	2
12	Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival 2023 ·Cancer Medicine ·Kevin C. Soares, Joshua S. Jolissaint, (unknown), Kenneth Seier, Mithat Gönen, Carlie Sigel, (unknown), Andrea Cercek, James J. Harding, Nancy E. Kemeny, Louise C. Connell, Bas Groot Koerkamp, Vinod P. Balachandran, Michael I. D’Angelica, Jeffrey A. Drebin, T. Peter Kingham, Alice C. Wei, William R. Jarnagin	4
13	Association of genomic profiles and survival in early onset and screening‐age colorectal cancer patients with liver metastases resected over 15 years 2022 ·Journal of Surgical Oncology ·Raja R. Narayan, Victoria G. Aveson, Joanne F. Chou, Henry Walch, Francisco Sánchez-Vega, Gustavo dos Santos Fernandes, Vinod P. Balachandran, Michael I. D’Angelica, Jeffrey A. Drebin, William R. Jarnagin, Alice C. Wei, Andrea Cercek, Mithat Gönen, Nikolaus Schultz, T. Peter Kingham	5
14	Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection 2021 ·Clinical Cancer Research ·Joshua S. Jolissaint, Kevin C. Soares, Kenneth Seier, Ritika Kundra, Mithat Gönen, (unknown), Thomas Boerner, Carlie Sigel, Ramyasree Madupuri, Efsevia Vakiani, Andrea Cercek, James J. Harding, Nancy E. Kemeny, Louise C. Connell, Vinod P. Balachandran, Michael I. D’Angelica, Jeffrey A. Drebin, T. Peter Kingham, Alice C. Wei, William R. Jarnagin	30
15	Colorectal cancer statistics, 2020 breakdown → 2020 ·CA A Cancer Journal for Clinicians ·Rebecca L. Siegel, Kimberly D. Miller, Ann Goding Sauer, Stacey A. Fedewa, Lynn F. Butterly, Joseph C. Anderson, Andrea Cercek, Robert A. Smith, Ahmedin Jemal	3624
16	Genomic stratification beyond Ras/B‐Raf in colorectal liver metastasis patients treated with hepatic arterial infusion 2019 ·Cancer Medicine ·J. Joshua Smith, Walid K. Chatila, Francisco Sánchez-Vega, Jashodeep Datta, Louise C. Connell, Bryan Szeglin, (unknown), Taryn Boucher, (unknown), Isaac Wasserman, Chao Wu, Andrea Cercek, Jaclyn F. Hechtman, (unknown), William R. Jarnagin, Julio García‐Aguilar, Michael I. D’Angelica, Rona Yaeger, Nikolaus Schultz, Nancy E. Kemeny	8
17	Mechanisms of Acquired Resistance to BRAF V600E Inhibition in Colon Cancers Converge on RAF Dimerization and Are Sensitive to Its Inhibition 2017 ·Cancer Research ·Rona Yaeger, Zhan Yao, David M. Hyman, Jaclyn F. Hechtman, Efsevia Vakiani, HuiYong Zhao, Wenjing Su, Lu Wang, Andrew Joelson, Andrea Cercek, José Baselga, Elisa de Stanchina, Leonard B. Saltz, Michael F. Berger, David B. Solit, Neal Rosen	60
18	Clinical Features and Outcomes of Patients with Colorectal Cancers Harboring NRAS Mutations 2017 ·Clinical Cancer Research ·Andrea Cercek, Maria Ignez Braghiroli, Joanne F. Chou, Jaclyn F. Hechtman, Nancy Kemeny, Leonard B. Saltz, Marinela Capanu, Rona Yaeger	58
19	Colorectal Cancer Liver Metastasis: Evolving Paradigms and Future Directions 2017 ·Cellular and Molecular Gastroenterology and Hepatology ·Luai Zarour, Sudarshan Anand, Kevin G. Billingsley, William H. Bisson, Andrea Cercek, Michael F. Clarke, Lisa M. Coussens, Charles E. Gast, Cristina B. Geltzeiler, Lissi Hansen, Katherine A. Kelley, Charles D. Lopez, Shushan Rana, Rebecca Ruhl, Vassiliki L. Tsikitis, Gina M. Vaccaro, Melissa H. Wong, Skye C. Mayo	198
20	Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF -Mutant Metastatic Colorectal Cancer Patients 2015 ·Clinical Cancer Research ·Rona Yaeger, Andrea Cercek, Eileen M. O’Reilly, Diane Reidy‐Lagunes, Nancy E. Kemeny, (unknown), Marinela Capanu, Marc J. Gollub, Neal Rosen, Michael F. Berger, Mario E. Lacouture, Efsevia Vakiani, Leonard B. Saltz	221

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact